By integrating multiple disciplines centered on translational sciences, we can tether clinically impactful research to the enhancement of patient care.

Oncogenic Signatures

Develop genomic methods for predicting signaling network activation in normal, premalignant and tumor cells.

Breast Cancer Phenotypes

Determine breast cancer tumor phenotypes using multi-pathway and multi-omic modeling.

Tumor Heterogeneity

Investigate tumor evolution over the course of a patient’s treatment.

Bioinformatic Software

Develop tools for cancer detection and progression, multi-omic gene set enrichment analysis, and determining pathway activation levels.

Biomarkers

Develop of drug response biomarkers to match the right drug to each patient.

Clinical Trails

Initiate clinical that test the accuracy of genomic drug response biomarkers.